OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
14.24
-0.41 (-2.80%)
Dec 5, 2025, 4:00 PM EST - Market closed
OptimizeRx Employees
As of December 31, 2024, OptimizeRx had 129 total employees, including 128 full-time and 1 part-time employees. The number of employees decreased by 7 or -5.15% compared to the previous year.
Employees
129
Change (1Y)
-7
Growth (1Y)
-5.15%
Revenue / Employee
$848,884
Profits / Employee
$264
Market Cap
265.44M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OPRX News
- 4 weeks ago - OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance - GlobeNewsWire
- 6 weeks ago - OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET - GlobeNewsWire
- 2 months ago - 4 Top AI-Powered Healthcare Stocks - Seeking Alpha
- 2 months ago - OptimizeRx: How The Stock Is Changing Pharma Marketing - Seeking Alpha
- 3 months ago - OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference - GlobeNewsWire
- 3 months ago - OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising - GlobeNewsWire
- 3 months ago - OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth - GlobeNewsWire